Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone and choice of words, like 'fantastic,' 'refreshing update,' and mentioning 'management strategies,' reflect a positive reception and active interest. Discussions about key points such as the importance of ICS and biologics demonstrate deep engagement, while references to advancements and management approaches imply the article's potential impact on clinical practices.
The posts largely express approval and positive acknowledgment of the article's content, especially highlighting advancements and management strategies.
Multiple discussions indicate a strong interest, with references to specific improvements, biologics, and management plans.
Posts incorporate detailed points, such as phenotypes and treatment approaches, showing active engagement beyond surface-level comments.
The discussions suggest the article could influence practice by emphasizing new treatment options and guidance, though direct claims of widespread change are limited.
Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults with asthma (even mild) should be on PRN SABA without ICS 2. Multiple biologics exist for severe 3. Self-mgmt & action plans https://t.co/howdsCgxNm
Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenotyoes (allergic vs eosinophilic) Endotypes (Hi vs Low Th2) and special considerations (biological, Thunderstorm, Covid19) all in one! https://t.co/LBPFotE6dV
@MarshallBBurke Google pointed me to this article titled; "Overview of recent advancements in asthma management". A richer society invests more in medical research and medical training to help those who are afflicted to recover. #adaptation through development https://t.co/492ajzPzri
Overview of #recent #advancements in #asthma #management https://t.co/G5zp1jgB5T https://t.co/vPooA9OEXo
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @Aidan_Baron: Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenoty…
This episode features leading respiratory physicians discussing current best practices in diagnosing and treating severe asthma, including inhaled corticosteroids, monoclonal antibodies, lifestyle modifications, and…
@MarshallBBurke Google pointed me to this article titled; "Overview of recent advancements in asthma management". A richer society invests more in medical research and medical training to help those who are afflicted to recover. #adaptation through development https://t.co/492ajzPzri
RT @Aidan_Baron: Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenoty…
Overview of #recent #advancements in #asthma #management https://t.co/G5zp1jgB5T https://t.co/vPooA9OEXo
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @Aidan_Baron: Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenoty…
RT @Aidan_Baron: Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenoty…
RT @Aidan_Baron: Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenoty…
RT @Aidan_Baron: Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenoty…
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
RT @Aidan_Baron: Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenoty…
RT @dr_ashwitt: Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults w…
Kudos @dr_ashwitt on this fantastic & refreshing update on Asthma Dx and Management Nice to have a clear guide on Phenotyoes (allergic vs eosinophilic) Endotypes (Hi vs Low Th2) and special considerations (biological, Thunderstorm, Covid19) all in one! https://t.co/LBPFotE6dV
Excited to share our paper -‘Overview of recent advancements in asthma management’ via @The_IMJ Key points 1. No adults with asthma (even mild) should be on PRN SABA without ICS 2. Multiple biologics exist for severe 3. Self-mgmt & action plans https://t.co/howdsCgxNm
A
DB
MK
AB
DS
D
JD
MR
K
DS
JS
K
YO
SL
BM
EH
AS